Connection

David Potter to Female

Back to Details
This is a "connection" page, showing publications David Potter has written about Female.
David Potter
Connection Strength
0.187
Female
  1. Bremazocine increases C-type natriuretic peptide levels in aqueous humor and enhances outflow facility. J Pharmacol Exp Ther. 2004 May; 309(2):548-53.
    View in: PubMed
    Score: 0.012
  2. Biodegradable calcium phosphate nanoparticles as a new vehicle for delivery of a potential ocular hypotensive agent. J Ocul Pharmacol Ther. 2002 Dec; 18(6):507-14.
    View in: PubMed
    Score: 0.011
  3. Ocular hypotension induced by electroacupuncture. J Ocul Pharmacol Ther. 2002 Aug; 18(4):293-305.
    View in: PubMed
    Score: 0.011
  4. Central imidazoline (I(1)) receptors modulate aqueous hydrodynamics. Curr Eye Res. 2001 May; 22(5):358-66.
    View in: PubMed
    Score: 0.010
  5. Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors. Exp Eye Res. 2001 Mar; 72(3):331-9.
    View in: PubMed
    Score: 0.010
  6. Mechanisms and sites of ocular action of 7-hydroxy-2-dipropylaminotetralin: a dopamine(3) receptor agonist. J Pharmacol Exp Ther. 2000 Jun; 293(3):710-6.
    View in: PubMed
    Score: 0.009
  7. Peripheral and central effects of naphazoline on ocular hydrodynamics. Involvement of imidazoline receptors, ANP, and Gi proteins. Ann N Y Acad Sci. 1999 Jun 21; 881:388-91.
    View in: PubMed
    Score: 0.009
  8. Potential mechanisms of moxonidine-induced ocular hypotension: role of norepinephrine. J Ocul Pharmacol Ther. 1997 Dec; 13(6):489-96.
    View in: PubMed
    Score: 0.008
  9. Moxonidine-induced inhibition of norepinephrine release in monkey and rabbit ciliary bodies: role of cGMP. Pharmacology. 1997 Oct; 55(4):211-6.
    View in: PubMed
    Score: 0.008
  10. Oxymetazoline: potential mechanisms of inhibitory effects on aqueous humor dynamics. Pharmacology. 1996 Oct; 53(4):259-70.
    View in: PubMed
    Score: 0.007
  11. Rilmenidine-induced ocular hypotension: role of imidazoline1 and alpha 2 receptors. Curr Eye Res. 1996 Sep; 15(9):943-50.
    View in: PubMed
    Score: 0.007
  12. Ocular action of an opioid peptide, DPDPE. J Ocul Pharmacol Ther. 1996; 12(2):131-9.
    View in: PubMed
    Score: 0.007
  13. Ocular actions of moxonidine: a possible role for imidazoline receptors. J Pharmacol Exp Ther. 1994 Jun; 269(3):897-904.
    View in: PubMed
    Score: 0.006
  14. Ocular hypotensive action of a dopaminergic (DA2) agonist, 2,10,11-trihydroxy-N-n-propylnoraporphine. J Pharmacol Exp Ther. 1993 Nov; 267(2):822-7.
    View in: PubMed
    Score: 0.006
  15. Ocular actions of an octahydrobenzo[f]quinoline: Ha117. Eur J Pharmacol. 1993 May 12; 236(1):61-8.
    View in: PubMed
    Score: 0.006
  16. Comparative effects of alpha-2 and DA-2 agonists on intraocular pressure in pigmented and nonpigmented rabbits. J Ocul Pharmacol. 1993; 9(3):187-99.
    View in: PubMed
    Score: 0.006
  17. Allicin-induced hypotension in rabbit eyes. J Ocul Pharmacol. 1993; 9(3):201-9.
    View in: PubMed
    Score: 0.006
  18. Medetomidine-induced alterations of intraocular pressure and contraction of the nictitating membrane. Invest Ophthalmol Vis Sci. 1991 Sep; 32(10):2799-805.
    View in: PubMed
    Score: 0.005
  19. Frizzled 4 is required for retinal angiogenesis and maintenance of the blood-retina barrier. Invest Ophthalmol Vis Sci. 2011 Aug 16; 52(9):6452-61.
    View in: PubMed
    Score: 0.005
  20. Ocular inhibitory effects of the dopamine DA2 agonist (Ha-118) in cats and rabbits. J Auton Pharmacol. 1990 Jun; 10(3):153-61.
    View in: PubMed
    Score: 0.005
  21. Effect of the calcium antagonist, nifedipine, on ischemic retinal dysfunction. J Ocul Pharmacol. 1990; 6(4):293-9.
    View in: PubMed
    Score: 0.005
  22. Opioid receptor-activation: retina protected from ischemic injury. Invest Ophthalmol Vis Sci. 2009 Aug; 50(8):3853-9.
    View in: PubMed
    Score: 0.004
  23. Aporphine derivatives affect ocular function in diverse ways. Curr Eye Res. 1987 Oct; 6(10):1227-36.
    View in: PubMed
    Score: 0.004
  24. Cianergoline lowers intraocular pressure in rabbits and monkeys and inhibits contraction of the cat nictitans by suppressing sympathetic neuronal function. J Ocul Pharmacol. 1987; 3(4):309-21.
    View in: PubMed
    Score: 0.004
  25. Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys. Curr Eye Res. 1986 Sep; 5(9):665-76.
    View in: PubMed
    Score: 0.004
  26. The ocular effects of xylazine in rabbits, cats, and monkeys. J Ocul Pharmacol. 1986; 2(1):9-21.
    View in: PubMed
    Score: 0.003
  27. Mechanism of the ocular hypotensive action of ketanserin. J Ocul Pharmacol. 1985; 1(2):137-47.
    View in: PubMed
    Score: 0.003
  28. An in vivo model for dissociating alpha 2-and DA2-adrenoceptor activity in an ocular adnexa: utility of the cat nictitating membrane preparation. Curr Eye Res. 1984 Nov; 3(11):1289-98.
    View in: PubMed
    Score: 0.003
  29. Effects of ergoline derivatives on intraocular pressure and iris function in rabbits and monkeys. Curr Eye Res. 1982-1983; 2(5):281-8.
    View in: PubMed
    Score: 0.003
  30. Role of glucagon in the hyperglycemic response to catecholamines in fasted baboons. Pharmacology. 1978; 17(4):221-6.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.